Core Scientific reported $215.4 million in colocation revenue for the third quarter of 2026, up from $136.7 million in the prior quarter and $15 million a year earlier. It said it was billing for 485 megawatts as of September 30, representing more than $700 million in average annualized colocation revenue. The company is approaching full delivery under its first colocation agreement, but construction under a second agreement and further billing increases remain unfinished.
Core Scientific reported about $1.18 billion in quarterly net income, which it said benefited from a non-cash change in the fair value of warrants. Adjusted EBITDA was $133.6 million, while capital expenditure was $985.1 million.
